1. Home
  2. BLMN vs AQST Comparison

BLMN vs AQST Comparison

Compare BLMN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$6.10

Market Cap

553.2M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
AQST
Founded
1988
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
553.2M
504.0M
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
BLMN
AQST
Price
$6.10
$4.08
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$8.38
$9.00
AVG Volume (30 Days)
2.0M
1.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
4.70%
N/A
EPS Growth
106.71
N/A
EPS
0.10
N/A
Revenue
$4,213,346,000.00
$67,430,000.00
Revenue This Year
$2.07
$10.08
Revenue Next Year
$1.81
$49.60
P/E Ratio
$63.60
N/A
Revenue Growth
N/A
0.77
52 Week Low
$5.19
$2.22
52 Week High
$10.70
$7.55

Technical Indicators

Market Signals
Indicator
BLMN
AQST
Relative Strength Index (RSI) 49.46 45.90
Support Level $5.40 $3.70
Resistance Level $6.12 $4.32
Average True Range (ATR) 0.32 0.15
MACD 0.04 -0.01
Stochastic Oscillator 48.28 22.09

Price Performance

Historical Comparison
BLMN
AQST

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: